Hospira 1Q Revenues: $888.7 million (+14%) 1Q Earnings: $65.4 million (loss of $29.4 million 1Q07) Comments: In the Americas, pharmaceuticals revenues grew was 11% to $462.6 million. However, the “Other Pharmaceuticals” unit, which   includes injectables and contract revenues, dropped 3% to $121.9   million. Asia Pacific pharmaceuticals revenue was $49.7 million   (+58%). 1Q07 loss includes $66.2 million of acquired in-process R&D   charges related to the Mayne Pharm...